Campaign to prioritise disabled children as Pfizer vaccine approved for use in 12- to 15-year-olds

Fiona Simpson
Friday, June 4, 2021

The Pfizer-Biontech Covid-19 vaccine has been approved for use for 12- to 15-year-olds sparking calls to prioritise diasbled children if it is rolled-out.

The jab has already been approved for young people aged 16 and older. Picture: Adobe Stock
The jab has already been approved for young people aged 16 and older. Picture: Adobe Stock

Register now to continue reading

Thank you for visiting Children & Young People Now and making use of our archive of more than 60,000 expert features, topics hubs, case studies and policy updates. Why not register today and enjoy the following great benefits:

  • Free access to 4 subscriber-only articles per month
  • Unlimited access to news and opinion
  • Email newsletter providing advice and guidance across the sector
Register Now

CYP Now Digital membership

  • Latest digital issues
  • Latest online articles
  • Archive of more than 60,000 articles
  • Unlimited access to our online Topic Hubs
  • Archive of digital editions
  • Themed supplements

From £15 / month

Subscribe

CYP Now Magazine

  • Latest print issues
  • Themed supplements

From £12 / month

Subscribe